List of registered products

Nikomex 2 ml No.10

Solution for injection 50 mg/ml 2 ml in ampoules No.10

Nikomex 2 ml No.10

NIKOMEX 2 ml No.10

Solution for injection 50 mg/ml 2 ml in ampoules No.10

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions.

Marketing Authorization No. UA/15072/01/01

Nikomex 5 ml No.5

Solution for injection 50 mg/ml 5 ml in ampoules No.5

Nikomex 5 ml No.5

NIKOMEX 5 ml No.5

Solution for injection 50 mg/ml 5 ml in ampoules No.5

1 ml of the solution contains 50 mg of ethylmethylhydroxypyridine succinate

Free-radical process inhibitor which increases resistance of the organism to disturbing factors and oxygen-related pathological conditions.

Marketing Authorization No. UA/15072/01/01

Haemaxam

Solution for injection 50 mg/ml5 ml in ampoules No.10

Haemaxam

HAEMAXAM

Solution for injection 50 mg/ml5 ml in ampoules No.10

1 ml of the solution contains 50 mg of tranexamic acid.

Starting therapy product used during the hemorrhages of different localization.

 

 

Marketing Authorization No. UA/13418/01/01

Emeton 2 ml No.5

Solution for injection 2 mg/ml 2 ml in ampoules No.5

Emeton 2 ml No.5

EMETON 2 ml No.5

Solution for injection 2 mg/ml 2 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3.

Marketing Authorization No. UA/13447/01/01

Emeton 4 ml No.5

Solution for injection 2 mg/ml 4 ml in ampoules No.5

Emeton 4 ml No.5

EMETON 4 ml No.5

Solution for injection 2 mg/ml 4 ml in ampoules No.5

Antiemetic product of central effect, selective antagonist of serotonin receptors 5HT3.

Marketing Authorization No. UA/13447/01/01

Lasoleks

Solution for injection 7.5 mg/ml 2 ml in ampoules No.5

Lasoleks

LASOLEKS

Solution for injection 7.5 mg/ml 2 ml in ampoules No.5, No.20 or No.50.

Mucolytic product. It increases lung secretion, increases lung surfactant release and also stimulates ciliary epithelium activity, which results in better mucus release and its excretion and eases  cough.

Marketing Authorization No. UA/12750/01/01

Bupivacaine

Solution for injection 5 mg/ml 10 ml in ampoules No.10.

Bupivacaine

BUPIVACAINE

Solution for injection 5 mg/ml 10 ml in ampoules No.10.

1 ml of the solution contains 5 mg of bupivacaine hydrochloride.

Drug of choice being used for epidural, conduction and infiltration anesthesia if a significant long-lasting effect is needed.

Marketing Authorization No. UA/13416/01/01

Bupivacaine spinal

Solution for injection 5 mg/ml 4 ml in ampoules No.5

Bupivacaine spinal

BUPIVACAINE SPINAL

Solution for injection 5 mg/ml 4 ml in ampoules No.5

1 ml of the solution contains 5 mg of bupivacaine hydrochloride.

Highly-effective product for spinal anesthesia.

Marketing Authorization No. UA/13417/01/01


To consumersTo specialists To partners
Authorization
*
*
*
*
*
*
Password generation